{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "10090498",
  "DateCompleted": {
    "Year": "1999",
    "Month": "06",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0163-4453",
      "JournalIssue": {
        "Volume": "38",
        "Issue": "1",
        "PubDate": {
          "Year": "1999",
          "Month": "Jan"
        }
      },
      "Title": "The Journal of infection",
      "ISOAbbreviation": "J Infect"
    },
    "ArticleTitle": "CCR5 genotype and HIV-1 infection in perinatally-exposed infants.",
    "Pagination": {
      "StartPage": "9",
      "EndPage": "11",
      "MedlinePgn": "9-11"
    },
    "Abstract": {
      "AbstractText": [
        "The CCR5 chemokine receptor is required by non-syncytium HIV-1 strains to infect target cells. A 32 base pair deletion (delta32) in the CCR5 gene causes a structural CCR5 modification that does not permit HIV-1 entry into cells. The rate of the CCR5 delta32 was investigated in 137 children born from HIV-infected mothers. Overall, five (10.6%) of 47 HIV-infected infants showed the defect in heterozygosis vs. eight (8.9%) of 90 uninfected children. No CCR5 delta32 homozygotes were found. Interestingly, among infected children, five (21.7%) of 23 showing a slow disease progression were heterozygous for the CCR5 delta32, meanwhile none of the 24 infants with rapid disease course had the deletion (P = 0.022). In conclusion, the CCR5 delta32 defect does not protect against vertical HIV-1 transmission, but is associated with a delayed disease progression in HIV-infected children."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Servicio de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain."
          }
        ],
        "LastName": "Mas",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Espa\u00f1ol",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Heredia",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Pedraza",
        "ForeName": "M A",
        "Initials": "MA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hernandez",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Caragol",
        "ForeName": "I",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fernando",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bertran",
        "ForeName": "J M",
        "Initials": "JM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Alcami",
        "ForeName": "J",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Soriano",
        "ForeName": "V",
        "Initials": "V"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Infect",
    "NlmUniqueID": "7908424",
    "ISSNLinking": "0163-4453"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, CCR5"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genotype"
    },
    {
      "QualifierName": [
        "etiology",
        "genetics",
        "pathology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "HIV-1"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Heterozygote"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant, Newborn"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infectious Disease Transmission, Vertical"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Loss of Heterozygosity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pregnancy"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Receptors, CCR5"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Sequence Deletion"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "White People"
    }
  ]
}